C84.A3Cutaneous T-cell lymphoma, unspecified, intra-abdominal lymph nodes. C84. A3 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
Cutaneous T-cell lymphoma causes scaly patches or bumps called lesions or tumors. The cancer is also known as lymphoma of the skin. It is a type of non-Hodgkin lymphoma. Cutaneous T-cell lymphoma is usually a slow-growing cancer. It develops over many years.
Symptoms of T-cell lymphomaSwollen lymph nodes.Fever.Night sweats.Weight loss.Fatigue.Rash or itchy skin.Pain in the chest, abdomen or bones.Mar 24, 2022
Most CTCLs typically fall into the category of indolent (i.e. chronic) lymphomas – treatable, but not curable and usually not life-threatening.
T-cell lymphoma is not curable but it is treatable. Yale Medicine's Department of Dermatology offers expert, multidisciplinary care and advanced treatments, including phototherapy for this unusual type of lymphoma.
T-cell lymphomas make up less than 15% of non-Hodgkin lymphomas in the United States. These are types of lymphoma that affect T lymphocytes. There are many types of T-cell lymphoma, but they are all fairly rare.Aug 1, 2018
Early cutaneous T-cell lymphomas (CTCL) may share many clinical and histological features with other autoimmune and inflammatory conditions. We present four patients who demonstrate the similarities in clinical presentation and histologic findings of CTCL, lupus panniculitis, and follicular mucinosis.
Patients who have stage IIB disease with cutaneous tumors have a median survival rate of 3.2 years (10-year survival rate of 42%) Patients who have stage III disease (generalized erythroderma) have a median survival rate of 4-6 years (10-year survival rate of 83%)Apr 20, 2020
Most T-cell skin lymphomas begin as patches of dry, discoloured skin (usually red), commonly on the buttocks or between the waist and shoulders (torso), but they can develop in other places. These patches may be itchy. They can look like more common skin conditions, such as dermatitis, eczema or psoriasis.
Cutaneous T-cell lymphomas make up 75% to 80% of cutaneous lymphomas. Most CTCLs are indolent (slow growing) and not life threatening. CTCLs are treatable, but they are not curable unless the patient undergoes a stem cell transplant (see later). There are several different types of CTCL.
individuals with stage IIB disease with cutaneous tumors have a median survival rate of 3.2 years (a 10-year survival rate of 42%). those with stage III disease (generalized erythroderma) have a median survival rate of 4-6 years (a 10-year survival rate of 83%).
Tumors of the hematopoietic and lymphoid tissues or haematopoietic and lymphoid malignancies are tumors that affect the blood, bone marrow, lymph, and lymphatic system.
Use a child code to capture more detail. ICD Code C84.A is a non-billable code.